Adicet Bio, Inc. (ACET)
ACET Stock Price Chart
Explore Adicet Bio, Inc. interactive price chart. Choose custom timeframes to analyze ACET price movements and trends.
ACET Company Profile
Discover essential business fundamentals and corporate details for Adicet Bio, Inc. (ACET) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
26 Jan 2018
Employees
152.00
Website
https://www.adicetbio.comCEO
Chen Schor BA, CPA,
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.
ACET Financial Timeline
Browse a chronological timeline of Adicet Bio, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 5 Nov 2025
EPS estimate is -$0.26.
Earnings released on 7 Aug 2025
EPS came in at -$0.34 falling short of the estimated -$0.32 by -6.25%.
Earnings released on 6 May 2025
EPS came in at -$0.31 surpassing the estimated -$0.34 by +8.82%.
Earnings released on 6 Mar 2025
EPS came in at -$0.32 surpassing the estimated -$0.37 by +13.51%.
Earnings released on 6 Nov 2024
EPS came in at -$0.34 surpassing the estimated -$0.36 by +5.56%.
Earnings released on 13 Aug 2024
EPS came in at -$0.33 surpassing the estimated -$0.35 by +5.71%.
Earnings released on 14 May 2024
EPS came in at -$0.35 matching the estimated -$0.35.
Earnings released on 19 Mar 2024
EPS came in at -$0.69 surpassing the estimated -$0.72 by +4.17%, while revenue for the quarter reached $12.89M , beating expectations by +1.98K%.
Earnings released on 8 Nov 2023
EPS came in at -$0.71 surpassing the estimated -$0.73 by +2.74%.
Earnings released on 9 Aug 2023
EPS came in at -$0.75 falling short of the estimated -$0.68 by -10.29%.
Earnings released on 9 May 2023
EPS came in at -$0.72 surpassing the estimated -$0.74 by +2.70%.
Earnings released on 15 Mar 2023
EPS came in at -$0.72 falling short of the estimated -$0.56 by -28.57%, while revenue for the quarter reached -$24.99M , missing expectations by -316.18%.
Earnings released on 8 Nov 2022
EPS came in at -$0.53 surpassing the estimated -$0.56 by +5.36%.
Earnings released on 10 Aug 2022
EPS came in at -$0.56 falling short of the estimated -$0.45 by -24.44%.
Earnings released on 12 May 2022
EPS came in at $0.10 surpassing the estimated -$0.18 by +155.56%, while revenue for the quarter reached $24.99M , beating expectations by +73.64%.
Earnings released on 15 Mar 2022
EPS came in at -$0.47 falling short of the estimated -$0.44 by -6.82%, while revenue for the quarter reached $5.47M , beating expectations by +31.31%.
Earnings released on 10 Nov 2021
EPS came in at -$0.44 falling short of the estimated -$0.38 by -15.79%, while revenue for the quarter reached $3.43M , beating expectations by +18.75%.
Earnings released on 12 Aug 2021
EPS came in at -$0.34 surpassing the estimated -$0.51 by +33.33%, while revenue for the quarter reached $4.81M , beating expectations by +0.02%.
Earnings released on 17 May 2021
EPS came in at -$0.82 falling short of the estimated -$0.50 by -64.00%, while revenue for the quarter reached -$3.98M , missing expectations by -23.74%.
Earnings released on 11 Mar 2021
EPS came in at -$0.46 surpassing the estimated -$0.88 by +47.73%, while revenue for the quarter reached $5.41M .
Earnings released on 5 Nov 2020
EPS came in at -$2.84 falling short of the estimated -$0.74 by -283.78%, while revenue for the quarter reached $3.03M , missing expectations by -26.23%.
Stock split effective on 16 Sept 2020
Shares were split 1 : 7 , changing the number of shares outstanding and the price per share accordingly.
ACET Stock Performance
Access detailed ACET performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.